Evidence-based medicine in surgery: The importance of both experimental and observational study designs

JAMA

Volumn 306, Issue 4, 2011, Pages 436-437

  Merkow, Ryan P ^a,b,c   Ko, Clifford Y ^a,d  

^a AMERICAN COLLEGE OF SURGEONS   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE;

BARIATRIC SURGERY; BONE MARROW METASTASIS; BREAST CANCER; CANCER SURVIVAL; EDITORIAL; EVIDENCE BASED MEDICINE; EXPERIMENTAL STUDY; GASTROESOPHAGEAL REFLUX; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MASTECTOMY; MICROMETASTASIS; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; SENTINEL LYMPH NODE BIOPSY; STANDARDIZATION;

EID: 79960720031     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1059     Document Type: Editorial

References (12)

1. Kohn LT, Corrigan JM, Donaldson MS. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000.
2. Donabedian A. The end results of health care: Ernest Codman's contribution to quality assessment and beyond. Milbank Q. 1989;67(2):233-256. (Pubitemid 20278770)
3. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002; 347(8):567-575.
4. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233-1241. (Pubitemid 35176242)
5. Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically nodenegative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927-933.
6. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569-575.
7. Giuliano AE, Hawes D, Ballman KV, et al. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with earlystage invasive breast cancer. JAMA. 2011;306(4):385-393.
8. Maciejewski ML, Livingston EH, Smith VA, et al. Survival among high-risk patients after bariatric surgery. JAMA. 2011;305(23):2419-2426.
9. Galmiche JP, Hatlebakk J, Attwood S, et al; LOTUS Trial Collaborators. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA. 2011;305(19):1969-1977.
10. Attwood SE, Lundell L, Ell C, et al; LOTUS Trial Group. Standardization of surgical technique in antireflux surgery: the LOTUS Trial experience. World J Surg. 2008;32(6):995-998.
11. Lundell L, Miettinen P, Myrvold HE, et al; The Nordic GORD Study Group. Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial. Eur J Gastroenterol Hepatol. 2000;12(8):879-887. (Pubitemid 30663900)
12. Lundell L, Miettinen P, Myrvold HE, et al; Nordic GORD Study Group. Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis. Br J Surg. 2007;94(2):198-203. (Pubitemid 46340400)